CHEVY CHASE, Md., Dec. 24, 2020 /PRNewswire/ -- Roumell Asset
Management, LLC ("Roumell"), which owns 5.78% of the outstanding
shares of common stock of Enzo Biochem, Inc.(NYSE: ENZ) ("Enzo" or
"the Company"), filed definitive proxy materials yesterday with the
Securities and Exchange Commission in connection with the Company's
upcoming annual meeting of shareholders (the "Annual Meeting")
currently scheduled to be held on January 4, 2021.
![](https://mma.prnewswire.com/media/1391823/ENZ___Roumell_Letter_to_Shareholders_December_24.pdf?p=pdfthumbnail)
Roumell today also issued a letter to shareholders in support of
its two nominees and its proposals included in its definitive proxy
statement. Notably, Roumell has put forth two nominees and
presented a pair of proposals to reconstitute the Enzo board by
electing Roumell's two highly qualified and independent nominees:
Matthew M. Loar and Edward Terino. Roumell believes that the
director nominees nominated by Roumell will, if elected, utilize
their deep industry knowledge and prior experience on public
company boards to the benefit of shareholders, and will provide new
objective and independent perspectives to the Company's board of
directors (the "Board").
Roumell urges all shareholders to vote
the GREEN proxy card "FOR" both of its nominees,
as well as for its two business proposals. If Enzo
shareholders have voted the company's white proxy, a later-dated
GREEN proxy will revoke that vote.
Since time may be short before the Annual Meeting, Roumell urges
shareholders to vote by internet or telephone. Although the Company
has remained steadfast in its decision to keep the date of the
Annual Meeting as January 4, 2020,
Roumell hopes that the Board realizes that it would be in
shareholders' best interest to postpone the Annual Meeting until a
later date that would allow shareholders to form their own opinions
about the contested nature of the meeting.
Roumell believes that no harm or injury to the Company or
shareholders would occur if the Company delayed the date of the
Annual Meeting, and the decision to do so would signal the
Company's interest in and support for shareholder democracy. In the
alternative, Roumell believes that if the Company decides to refuse
to delay the Annual Meeting, such a decision would signal an
animosity for shareholders' interest and antipathy for shareholder
democracy.
Roumell seeks to remove from the Board Enzo's long-standing
Chairman & CEO, Dr. Elazar
Rabbani, who Roumell believes has overseen decades of value
destruction, while being paid egregious compensation.
Roumell's letter to shareholders, as well as its definitive
proxy statement can be found at www.saratogaproxy.com/Roumell
Should you have any questions or need assistance with voting,
please contact Saratoga Proxy Consulting LLC at (888) 368-0379 or
(212) 257-1311 or by email at info@saratogaproxy.com.
Contacts
Saratoga Proxy Consulting LLC
John Ferguson / Joe Mills, 212-257-1311
jferguson@saratogaproxy.com / jmills@saratogaproxy.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/roumell-asset-management-files-definitive-proxy-statement-and-sends-letter-to-enzo-biochem-shareholders-301198447.html
SOURCE Roumell Asset Management, LLC